Wu Qiwen's flu is cured, but he is still under medical observation, and he can't leave the laboratory yet, and the life science laboratory will always detect the level of NK cells in Wu Qiwen's body.

After the cessation of gene expression-inducing drugs, it will take some time for the number of NK cells in the body to decline completely.

Laboratories need to observe the effects of high levels of NK cells on human function and the immune system.

At the same time as the experiment, Gao Siqi's team began to write the experimental paper "Gene Induces Somatic Cell Differentiation NK Cells to Kill Ebola Virus".

Papers and experimental results will be submitted to the WHO, and the application for gene induction therapy in South Anafrica or Congolese endemic areas will be requested.

After a few days of observation, Wu Qiwen's physical condition was normal, and the level of NK cells was gradually approaching the normal trend.

The laboratory also found an unexpected news that Wu Qiwen's immunity was enhanced, and the laboratory simply struck while the iron was hot to carry out research on NK cells and human immune function.

Pangu Science and Technology Park, Life Science Laboratory.

Gao Siqi gave Xiao Ming the paper he had just written and said, "One step away." ”

Gao Siqi didn't know if this was good news, "The control of gene expression in the life science laboratory has become more proficient, and we are only one step away from the totipotency of expressing human genes on the basis of somatic cells." ”

Gao Siqi said this is more tongue-twisting, and the more direct expression is to give me a somatic cell with complete human genes, and I can create any part of a human being, even a human being.

This is a major breakthrough in the life sciences, but it is a no-go zone for ethics, law, and morality.

In fact, after the publication of the paper on gene expression regulation two years ago, there was this debate in the academic community, and everyone can expect this day to come.

The research results of gene regulation and expression have been a huge sensation in the academic community at the beginning, and many people in the industry have mentioned that this revolution in life science technology has the possibility of impacting the Nobel Prize in biology.

It now appears that much more has been achieved in the regulation of gene expression.

Xiao Ming set a red line for Gao Siqi's experiment, he said: "We can use this technology to create a liver, create a heart, create any organ or even limbs that can be used in the medical field, but we can't use it to create a person." ”

Xiao Ming is well aware of the value of gene expression control to humanity as a whole, and even to biology as a whole.

This technology can maximize the expression of gene combinations without modifying genes.

"I understand that this is currently a no-go zone in the field of human biology. Gao Siqi said: "But this technology will have a wider range of uses. We are currently working with a medical center to conduct a totipotency expression experiment to see if we can help people with disabilities. ”

The experiments that Gao Siqi is doing are not only a breakthrough in life science, but also a major breakthrough in the field of medicine.

Xiao Ming is also concerned about the cost of NK gene induction preparations.

Gao Siqi replied: "The production and manufacturing methods of NK gene inducers are different from those of cancer cell gene inhibition inducers, because the latter has different types of cancer, different gene sites and types, so the methods and treatment methods of inhibitors are different, and the cost is higher. The former is only aimed at inducing the production of NK cell populations, so it can be mass-produced, and in the future, it can be used as a drug preparation for the treatment of Ebola, influenza, HIV and even other viral infections, and the cost can be controlled within a certain range. ”

In the afternoon, Xiao Ming, experts from the life science laboratory and Xiao Chu jointly approved the paper, and then directly submitted it to the WHO Institute of Biomedical Sciences in Yanjing, along with the application for on-site clinical trials in the epidemic area.

……

The people of Xia have indeed had a wonderful Spring Festival, but the people in the Ebola-affected areas of West and Southern Africa are suffering from the first short rainy season of 2022.

The short rainy season usually lasts from February to April and lasts for a shorter period and receives less rainfall than the long rainy season.

However, this year's weather was noticeably more unusual, with the short rainy season receiving more rainfall than usual for the same period of the year.

In endemic areas, sewage, household garbage, sick excrement and other virus-bearing filth flow into tributaries near villages under the impact of sudden heavy rains, which flow into large rivers and flow downstream, into more villages and living areas, and even into cities.

The WHO's headquarters in Africa has responded to the Level 1 defense mechanism, allowing downstream villages to prepare themselves against the virus.

But much of West and Southern Africa is very backward, and most of the villages are still living on slash-and-burn farming, with no running water or electricity. The water source is the river, and the food comes from nature.

This is very difficult for the WHO to prevent and control the epidemic, and after February, there have been cases of out-of-town tourists traveling to the local area to be infected with Ebola deaths.

In response to such a situation, the WHO continued to negotiate with NL Gene Company in Maple Leaf Country, and NL Gene Company resolutely refused to compromise on the price, and the WHO did not have enough funds to control the local epidemic.

In fact, it is understandable for NL to do this, why should the vaccines that others have worked so hard to develop at a low price for you?

And Africa is not Asia or Europe, where vaccines can be sold at low prices and have a market for them, in Africa...... Do the villagers of African tribal villages use Western medicine, and can they afford it?

All NL companies that speak with capital and interests feel that this kind of investment will be wasted.

The WHO once again relented and urgently collected 300 million meters of rice from major member states to prepare and NL to purchase a batch of vaccines to deal with the epidemic in Africa.

The WHO paid a deposit of 30 million meters to NL and received the first batch of 300 sets of vaccines.

Unfortunately, the time has passed, and the Ebola that is currently raging in West Africa and southern Africa is still a subspecies of Ebola that is different from last year's Ebola.

Then NL's vaccine is ineffective against subspecies viruses.

The WHO's 30 million is in vain.

But it's not a big deal, NL said that if they add another 20% to the original price, they will redo the glycoprotein shell.

Isn't that rip-off!

WHO：……

The Maple Leaf Country is determined to settle on this business, and the global monopoly operation is unique and unique.

The war of words between the WHO and NL companies is also reported in the international market.

Netizens are divided into two factions.

One faction is a staunch supporter of NL and thinks that it should spend a lot of money on developing a vaccine that it should provide cheap aid.

One group strongly supports the WHO, believing that human beings should have universal values and that life should be respected no matter where they are or in any country.

Just when the WHO was in a hurry, the WHO's biomedical laboratory in Yanjing received the experimental paper and related applications from Pangu Technology.